OraSure Technologies, Inc. (OSUR)

CIK 0001116463 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-05) · 99.1
Q1-2026 8-K (2026-05-06) · 99.1 · 99.2
Latest FY-2025 8-K (2026-02-25) · 99.1 · 99.2
Q3-2025 8-K (2025-11-05) · 99.1 · 99.2
Q2-2025 8-K (2025-08-05) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1
FY-2024 8-K (2025-02-25) · 99.1
Q3-2024 8-K (2024-11-06) · 99.1
Q2-2024 8-K (2024-08-06) · 99.1
Q1-2024 8-K (2024-05-08) · 99.1
FY-2023 8-K (2024-02-27) · 99.1
Q3-2023 8-K (2023-11-07) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
—
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Income (loss)
Consolidated Statements of Comprehensive Loss (unaudited)
—
Consolidated Statements of Cash Flows
Consolidated Statements of Comprehensive (loss) Income
—
Consolidated Statements of Stockholders' Equity
—
Notes
Accrued Expenses and Other Current Liabilities
Business Combinations
Business Segment Information
Business Segments
—
Commitments and Contingencies
Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Earning (loss) Per Share
—
Goodwill and Other Intangible Assets
—
Government Capital Contracts
Income (loss) Per Share
—
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventories
Leases
—
Loss Per Share
—
Pay Vs Performance Disclosure
Property, Plant and Equipment
Property, Plant and Equipment, Net
—
Retirement Plans
—
Revenues
—
Stockholders' Equity
Subsequent Events
Summary of Significant Accounting Policies
Termination Benefits
The Company
—
Transition Costs
—